These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 29976931)
1. Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development. Astone M; Lai JKH; Dupont S; Stainier DYR; Argenton F; Vettori A Sci Rep; 2018 Jul; 8(1):10189. PubMed ID: 29976931 [TBL] [Abstract][Full Text] [Related]
2. Yap and Taz regulate retinal pigment epithelial cell fate. Miesfeld JB; Gestri G; Clark BS; Flinn MA; Poole RJ; Bader JR; Besharse JC; Wilson SW; Link BA Development; 2015 Sep; 142(17):3021-32. PubMed ID: 26209646 [TBL] [Abstract][Full Text] [Related]
3. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Miesfeld JB; Link BA Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909 [TBL] [Abstract][Full Text] [Related]
4. Yap1/Taz are essential for the liver development in zebrafish. Yi X; Yu J; Ma C; Li L; Luo L; Li H; Ruan H; Huang H Biochem Biophys Res Commun; 2018 Sep; 503(1):131-137. PubMed ID: 29859190 [TBL] [Abstract][Full Text] [Related]
12. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
13. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP. Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714 [TBL] [Abstract][Full Text] [Related]
14. Regulation of posterior body and epidermal morphogenesis in zebrafish by localized Yap1 and Wwtr1. Kimelman D; Smith NL; Lai JKH; Stainier DY Elife; 2017 Dec; 6():. PubMed ID: 29283341 [TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452 [TBL] [Abstract][Full Text] [Related]
16. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors. Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103 [TBL] [Abstract][Full Text] [Related]
17. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth. Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma. Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352 [TBL] [Abstract][Full Text] [Related]
19. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
20. Studying the Geroprotective Properties of YAP/TAZ Signaling Inhibitors on Golubev DA; Zemskaya NV; Gorbunova AA; Kukuman DV; Moskalev A; Shaposhnikov MV Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]